Corvus Pharmaceuticals In...

3.17
-0.01 (-0.31%)
At close: Apr 01, 2025, 3:59 PM
3.22
1.70%
After-hours: Apr 01, 2025, 07:55 PM EDT

Corvus Pharmaceuticals Ratios Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
PE Ratio -5.24 -3.13 -0.79 -2.64 -21.76 -3.65 -2.15 -3.81 -6.06 -9.28
PEG Ratio -0.06 0.06 -0.04 -0.01 0.24 0.28 0.06 -0.25 -0.11 -0.19
PS Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
PB Ratio 10.02 2.18 0.71 1.04 1.45 2.25 0.92 2.50 1.66 -9.35
P/FCF Ratio -12.83 -3.53 -1.45 -2.75 -3.01 -4.28 -2.44 -4.57 -7.34 -22.24
P/OCF Ratio -12.83 -3.53 -1.46 -2.75 -3.02 -4.28 -2.46 -4.59 -7.92 -25.67
OCF/S Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.03 0.04 0.05 0.04 0.03 0.04 n/a n/a n/a n/a
Quick Ratio 1.54 4.07 3.55 5.70 3.34 6.29 14.59 9.15 18.51 30.93
Current Ratio 1.54 4.07 3.49 5.65 3.31 6.22 14.51 9.06 18.36 31.16
Asset Turnover n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Interest Coverage -15.1 -14.78 -49.79 -2.58K -81.04 -22.39 -21.56 n/a -61.52 n/a
Return on Equity (ROE) n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Return on Assets (ROA) n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Return on Capital (ROIC) n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a